L.C. Pan
Global Research and Development
Pfizer
Inc., Groton
CT 06340
USA [corrected]
Name/email consistency: high
- Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue. Pan, L.C., Carpino, P.A., Lefker, B.A., Ragan, J.A., Toler, S.M., Pettersen, J.C., Nettleton, D.O., Ng, O., Pirie, C.M., Chidsey-Frink, K., Lu, B., Nickerson, D.F., Tess, D.A., Mullins, M.A., MacLean, D.B., DaSilva-Jardine, P.A., Thompson, D.D. Endocrine (2001)